(2<i>S</i>,3<i>R</i>,6<i>R</i>)-2-[(<i>R</i>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<i>H</i>-Pyran-3-ol

(2<i>S</i>,3<i>R</i>,6<i>R</i>)-2-[(<i>R</i>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<i>H</i>-Pyran-3-ol

(2<i>S</i>,3<i>R</i>,6<i>R</i>)-2-[(<i>R</i>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<i>H</i>-pyran-3-ol was isolated in 18% after treating the glucose derived (5<i>R</i>,6<i>S</i>,7<i>R</i>)-5...

Full description

Bibliographic Details
Main Authors: Jack Bennett, Paul V. Murphy
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Molbank
Subjects:
glucose
tetrahydropyran
deprotection
cyclisation
functionalized scaffold
Online Access:https://www.mdpi.com/1422-8599/2020/2/M1140

Internet

https://www.mdpi.com/1422-8599/2020/2/M1140

Similar Items